Close Menu

NEW YORK (360Dx) – Biopharma firm iBio said today it has partnered with TheoremDx to develop proteins for use in rapid diagnostic testing of tropical diseases.

Under the collaboration, iBio will develop and produce proteins that TheoremDx will use with its point-of-care testing platform to diagnose diseases including the Zika, Dengue, Chikungunya, and West Nile viruses and to develop an improved HIV test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Sponsored by

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.  

Sponsored by
Bionano Genomics

This webinar will review a recent study that applied whole-genome sequencing and optical genome mapping to identify a large number of previously undetected somatic structural variants in leukemia samples.